Status:
COMPLETED
Triggering of Final Oocyte Maturation With GnRHa (Buserelin) in GnRH Antagonist Cycles
Lead Sponsor:
Regionshospitalet Viborg, Skive
Conditions:
OHSS (Ovarian Hyperstimulation)
Eligibility:
FEMALE
20-39 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to possibly further improve the clinical outcome and explore the incidence of OHSS in patients, who have final oocyte maturation with GnRHa (Buserelin) in GnRH antagonist ...
Eligibility Criteria
Inclusion
- Patient complying with the conditions for IVF or ICSI treatment
- Female age over 20 years and under 40 years
- Normal regular cycle and patients with oligomenorrhea
- BMI \> 18 and \< 35
- each patient contributes with one cycle only
Exclusion
- Significant disturbances in the woman (diabetes, epilepsy, liver/renal/heart disease, metabolic disorder)
- Patients with \> 25 follicles on the day of triggering ovulation
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2011
Estimated Enrollment :
384 Patients enrolled
Trial Details
Trial ID
NCT00627406
Start Date
January 1 2009
End Date
December 1 2011
Last Update
November 27 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Fertility Clinic, Regional Hospital of Skive
Skive, Denmark, 7800